SelectQuote Inc (SLQT)
NYSE:SLQT
Want to see SLQT full AI Analyst Report?
SLQT Stock Chart & Stats
$0.78
$0.12(2.90%)
At close: 4:00 PM EST
$0.78
$0.12(2.90%)
Day’s Range― - ―
52-Week Range$0.56 - $2.77
Previous CloseN/A
Volume368.25K
Average Volume (3M)2.44M
Market Cap
$181.64M
Enterprise Value$544.26M
Total Cash (Recent Filing)$35.21M
Total Debt (Recent Filing)$403.13M
Price to Earnings (P/E)1.9
Beta1.50
Next Earnings
Sep 16, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding176,347,780
10 Day Avg. Volume1,629,728
30 Day Avg. Volume2,444,794
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.73
Price to Sales (P/S)0.27
P/FCF Ratio-30.25
Enterprise Value/Market Cap3.00
Enterprise Value/Revenue0.33
Enterprise Value/Gross Profit0.56
Enterprise Value/Ebitda3.78
Forecast
1Y Price Target
$4.00Price Target Upside412.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.05
Revenue Forecast (FY)$1.65B
Bulls Say, Bears Say
Bulls Say
Revenue & Profitability RecoverySelectQuote has re-established revenue growth and returned to positive adjusted EBITDA, demonstrating scaled operations and improved cost control. That recovery indicates durable revenue-generating capacity across segments and a stronger base to convert incremental growth into sustainable operating profits if execution continues.
Senior Segment Backbook VisibilityA large commissions receivable and above‑target recapture rates provide multi‑period cash‑flow visibility tied to renewals, underpinning predictable future revenue streams unique to Medicare distribution. This backbook reduces reliance on new‑sale volatility and supports longer‑term cash generation if persistency holds.
SelectRx Scale & EfficiencySelectRx is scaling rapidly with strong membership and shipment growth plus a clear near‑term EBITDA target. Operational improvements (facility efficiency, faster fulfillment) create durable margin upside and a pathway to diversify revenue away from commissions toward recurring healthcare services cash flows.
Bears Say
Weak Cash GenerationDespite profit recovery, negative operating and free cash flows in recent periods show earnings have not reliably converted to cash. This elevates funding and execution risk, limiting flexibility to invest, de-lever, or withstand adverse approval/timing shocks absent sustained cash conversion improvements.
NYSE Listing-compliance RiskA listing‑compliance notice creates a multi‑month strategic overhang that can force management into time‑sensitive, potentially dilutive actions and distract from operations. The risk can constrain capital raising, affect partner confidence, and remain a structural governance and refinancing concern until cured.
Reliance On One-time Adjustments & Approval TimingNear‑term results benefited from a nonrecurring $14M adjustment and variable Medicare approval timing; earlier PBM reimbursement issues also signaled revenue sensitivity. Dependence on accounting adjustments and volatile approval/reimbursement dynamics undermines predictability of earnings and cash over the medium term.
SelectQuote News
SLQT FAQ
What was SelectQuote Inc’s price range in the past 12 months?
SelectQuote Inc lowest stock price was $0.56 and its highest was $2.77 in the past 12 months.
What is SelectQuote Inc’s market cap?
SelectQuote Inc’s market cap is $181.64M.
When is SelectQuote Inc’s upcoming earnings report date?
SelectQuote Inc’s upcoming earnings report date is Sep 16, 2026 which is in 103 days.
How were SelectQuote Inc’s earnings last quarter?
SelectQuote Inc released its earnings results on May 05, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of -$0.008 by $0.118.
Is SelectQuote Inc overvalued?
According to Wall Street analysts SelectQuote Inc’s price is currently Undervalued.
Does SelectQuote Inc pay dividends?
SelectQuote Inc does not currently pay dividends.
What is SelectQuote Inc’s EPS estimate?
SelectQuote Inc’s EPS estimate is -0.17.
How many shares outstanding does SelectQuote Inc have?
SelectQuote Inc has 176,347,780 shares outstanding.
What happened to SelectQuote Inc’s price movement after its last earnings report?
SelectQuote Inc reported an EPS of $0.11 in its last earnings report, beating expectations of -$0.008. Following the earnings report the stock price went up 52.522%.
Which hedge fund is a major shareholder of SelectQuote Inc?
Currently, no hedge funds are holding shares in SLQT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (412.82% Upside)
$4.00 (412.82% Upside)
Blogger Sentiment
Bullish
SLQT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 139.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.7%
Last 30 Days ▲ 8.6%
Last 30 Days ▲ 8.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.00%
12-Months-Change
Fundamentals
Return on Equity
15.28%
Trailing 12-Months
Asset Growth
3.00%
Trailing 12-Months
Company Description
SelectQuote Inc
SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related policies, including prescription drugs, dental, vision, and hearing plans; term life policies; and non-commercial auto and home property, and casualty policies. The company was incorporated in 1999 and is headquartered in Overland Park, Kansas.
SLQT Company Deck
SLQT Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial progress: revenue grew 6% to $431M, adjusted EBITDA rose 18% to $45M, Senior and Healthcare Services showed tangible improvements, SelectRx demonstrated membership and efficiency momentum, and management reiterated guidance and a path to stronger cash flow in fiscal 2027. Offsetting items include IRA-driven top-line effects, earlier PBM reimbursement headwinds (now reportedly stabilized), reliance on a $14M favorable change in estimate that aided results, and potential timing-related volatility in MA approval rates that could affect Q4. Management emphasized backbook visibility (nearly $1B commissions receivable) and multiple strategic options to close the valuation gap. On balance, operational strengths and clear pathways to improved cash flow outweigh the near-term headwinds and accounting nuances.View all SLQT earnings summariesSLQT Stock 12 Month Forecast
Average Price Target
$4.00
▲(412.82% Upside)
Technical Analysis
Ownership Overview
29.70% Insiders
7.31% Mutual Funds
10.51% Other Institutional Investors
43.66% Public Companies and
Individual Investors